Company patents
LivaNova USA, Inc.
LivaNova USA, Inc. shows a surprising shift in its patent strategy, with its dominant Electrotherapy / Radiation Therapy category, representing 96.3% of its portfolio, experiencing a significant decline of -38.9% in 2025 and -54.5% so far in 2026. This suggests a potential pivot away from its core, especially given the rapid 800.0% growth in Healthcare Informatics in 2024, despite its subsequent decline in 2025 and 2026, indicating an exploration of new, albeit volatile, areas.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
54 US filings (since 2023) · 3 categories · 5 themes
Systems that provide therapeutic stimulation or field therapy through wearable devices, often incorporating physiological sensing and closed-loop feedback for personalized and adaptive treatment.
Therapeutic application of electrical signals to nerves or tissues to modulate their activity, often using implantable devices, electrodes, and sophisticated programming for various conditions.
Design and application of devices that are inserted into the body or implanted to treat diseases, modulate physiological functions, or repair anatomical structures.
Systems that integrate digital technology, sensors, or connectivity to monitor, track, or automate aspects of medication administration, often providing data feedback, personalized recommendations, or secure logging.
Systems and methods for non-invasive or minimally invasive collection and analysis of physiological data (e.g., blood pressure, electrolytes, genetic markers, B cell repertoire) to assess patient health status, screen for conditions, or aid in diagnosis.
Patents
Showing 1-10 of 97